418 related articles for article (PubMed ID: 33848261)
1. Potential role of cannabidiol in Parkinson's disease by targeting the WNT/β-catenin pathway, oxidative stress and inflammation.
Vallée A; Vallée JN; Lecarpentier Y
Aging (Albany NY); 2021 Apr; 13(7):10796-10813. PubMed ID: 33848261
[TBL] [Abstract][Full Text] [Related]
2. Parkinson's Disease: Potential Actions of Lithium by Targeting the WNT/β-Catenin Pathway, Oxidative Stress, Inflammation and Glutamatergic Pathway.
Vallée A; Vallée JN; Lecarpentier Y
Cells; 2021 Jan; 10(2):. PubMed ID: 33503974
[TBL] [Abstract][Full Text] [Related]
3. Cannabidiol and the Canonical WNT/β-Catenin Pathway in Glaucoma.
Vallée A; Lecarpentier Y; Vallée JN
Int J Mol Sci; 2021 Apr; 22(7):. PubMed ID: 33917605
[TBL] [Abstract][Full Text] [Related]
4. ALCAR Exerts Neuroprotective and Pro-Neurogenic Effects by Inhibition of Glial Activation and Oxidative Stress via Activation of the Wnt/β-Catenin Signaling in Parkinsonian Rats.
Singh S; Mishra A; Shukla S
Mol Neurobiol; 2016 Sep; 53(7):4286-301. PubMed ID: 26223802
[TBL] [Abstract][Full Text] [Related]
5. Effects of cannabidiol interactions with Wnt/β-catenin pathway and PPARγ on oxidative stress and neuroinflammation in Alzheimer's disease.
Vallée A; Lecarpentier Y; Guillevin R; Vallée JN
Acta Biochim Biophys Sin (Shanghai); 2017 Oct; 49(10):853-866. PubMed ID: 28981597
[TBL] [Abstract][Full Text] [Related]
6. Possible actions of cannabidiol in obsessive-compulsive disorder by targeting the WNT/β-catenin pathway.
Vallée A; Lecarpentier Y; Vallée JN
Mol Psychiatry; 2022 Jan; 27(1):230-248. PubMed ID: 33837269
[TBL] [Abstract][Full Text] [Related]
7. Neuroprotective effects of cannabidiol on dopaminergic neurodegeneration and α-synuclein accumulation in C. elegans models of Parkinson's disease.
Muhammad F; Liu Y; Wang N; Zhao L; Zhou Y; Yang H; Li H
Neurotoxicology; 2022 Dec; 93():128-139. PubMed ID: 36108815
[TBL] [Abstract][Full Text] [Related]
8. Salidroside Protection Against Oxidative Stress Injury Through the Wnt/β-Catenin Signaling Pathway in Rats with Parkinson's Disease.
Wu DM; Han XR; Wen X; Wang S; Fan SH; Zhuang J; Wang YJ; Zhang ZF; Li MQ; Hu B; Shan Q; Sun CH; Lu J; Zheng YL
Cell Physiol Biochem; 2018; 46(5):1793-1806. PubMed ID: 29705802
[TBL] [Abstract][Full Text] [Related]
9. Tormentic acid confers protection against oxidative stress injury in rats with Parkinson's disease by targeting the Wnt/β-catenin signaling pathway.
Yue Y; Qiao B; Jiang X
Cell Mol Biol (Noisy-le-grand); 2020 Apr; 66(1):32-36. PubMed ID: 32359380
[TBL] [Abstract][Full Text] [Related]
10. Neuroprotective and Symptomatic Effects of Cannabidiol in an Animal Model of Parkinson's Disease.
Giuliano C; Francavilla M; Ongari G; Petese A; Ghezzi C; Rossini N; Blandini F; Cerri S
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445626
[TBL] [Abstract][Full Text] [Related]
11. Wnt/β-catenin signaling plays an essential role in α7 nicotinic receptor-mediated neuroprotection of dopaminergic neurons in a mouse Parkinson's disease model.
Liu Y; Hao S; Yang B; Fan Y; Qin X; Chen Y; Hu J
Biochem Pharmacol; 2017 Sep; 140():115-123. PubMed ID: 28551099
[TBL] [Abstract][Full Text] [Related]
12. Cannabidiol exerts protective effects in an in vitro model of Parkinson's disease activating AKT/mTOR pathway.
Gugliandolo A; Pollastro F; Bramanti P; Mazzon E
Fitoterapia; 2020 Jun; 143():104553. PubMed ID: 32184097
[TBL] [Abstract][Full Text] [Related]
13. Cannabidiol Protects Dopaminergic-like Neurons against Paraquat- and Maneb-Induced Cell Death through Safeguarding DJ-1CYS
Mendivil-Perez M; Felizardo-Otalvaro AA; Jimenez-Del-Rio M; Velez-Pardo C
ACS Chem Neurosci; 2023 Jun; 14(11):2159-2171. PubMed ID: 37220279
[TBL] [Abstract][Full Text] [Related]
14. Neuroprotective and Therapeutic Strategies against Parkinson's Disease: Recent Perspectives.
Sarkar S; Raymick J; Imam S
Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27338353
[TBL] [Abstract][Full Text] [Related]
15. Biological bases for a possible effect of cannabidiol in Parkinson's disease.
Ferreira-Junior NC; Campos AC; Guimarães FS; Del-Bel E; Zimmermann PMDR; Brum Junior L; Hallak JE; Crippa JA; Zuardi AW
Braz J Psychiatry; 2020 Apr; 42(2):218-224. PubMed ID: 31314869
[TBL] [Abstract][Full Text] [Related]
16. Therapies modulating insulin resistance in Parkinson's disease: A cross talk.
Sharma T; Kaur D; Grewal AK; Singh TG
Neurosci Lett; 2021 Apr; 749():135754. PubMed ID: 33610666
[TBL] [Abstract][Full Text] [Related]
17. Dopamine receptor activation mitigates mitochondrial dysfunction and oxidative stress to enhance dopaminergic neurogenesis in 6-OHDA lesioned rats: A role of Wnt signalling.
Mishra A; Singh S; Tiwari V; Chaturvedi S; Wahajuddin M; Shukla S
Neurochem Int; 2019 Oct; 129():104463. PubMed ID: 31078578
[TBL] [Abstract][Full Text] [Related]
18. Mangiferin alleviates 6-OHDA-induced Parkinson's disease by inhibiting AKR1C3 to activate Wnt signaling pathway.
Huang W; Wang Y; Huang W
Neurosci Lett; 2024 Jan; 821():137608. PubMed ID: 38142926
[TBL] [Abstract][Full Text] [Related]
19. Enhancing Beta-Catenin Activity via GSK3beta Inhibition Protects PC12 Cells against Rotenone Toxicity through Nurr1 Induction.
Zhang L; Cen L; Qu S; Wei L; Mo M; Feng J; Sun C; Xiao Y; Luo Q; Li S; Yang X; Xu P
PLoS One; 2016; 11(4):e0152931. PubMed ID: 27045591
[TBL] [Abstract][Full Text] [Related]
20. Ursolic acid attenuates oxidative stress in nigrostriatal tissue and improves neurobehavioral activity in MPTP-induced Parkinsonian mouse model.
Rai SN; Yadav SK; Singh D; Singh SP
J Chem Neuroanat; 2016 Jan; 71():41-9. PubMed ID: 26686287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
